Taubman’s PJT Establishes Health-Care M&A Cred With AbbVie (1)

June 25, 2019, 1:40 PM UTCUpdated: June 25, 2019, 2:53 PM UTC

Paul J. Taubman has long been one of Wall Street’s top telecom and media dealmakers. On June 25, he showed that his firm has become a force in healthcare M&A too.

PJT Partners Inc., the boutique investment bank Taubman founded in 2013, is co-advising AbbVie Inc. on its $63 billion deal for rival drugmaker Allergan Plc along with Morgan Stanley. Taubman spent 27 years at Morgan Stanley before starting PJT.

Paul Taubman
Photographer: Tina Fineberg/The New York Times via Redux

JPMorgan Chase & Co. is advising Allergan on the deal, the third biggest pharmaceuticals merger on record, according to data compiled by Bloomberg.

It’s the largest deal yet for ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.